AUXILIUM PHARMACEUTICALS INC Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flow

In millions of USD, except per-share amounts

	FY2013 12 months to Dec 31, 2013	FY2012 12 months to Dec 31, 2012	FY2011 12 months to Dec 31, 2011	FY2010 12 months to Dec 31, 2010
Net loss
Cash flows from operating activities:
Net income (loss)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization
Stock-based compensation
Amortization of purchased intangibles
Amortization of debt discount and issuance costs
Contingent consideration
Release of valuation allowance for deferred tax assets
Changes in operating assets and liabilities:
Increase in accounts receivable
Increase in inventories
Decrease (increase) in prepaid expenses, other current assets and other assets
Increase in accounts payable and accrued expenses
Increase (decrease) in deferred revenue
Increase (decrease) in deferred rent
Net cash provided by (used in) operating activities
Net cash provided by (used in) operating activities
Cash flows from investing activities:
Business acquisitions, net of cash acquired
Purchases of property and equipment
Purchases of short-term investments
Redemptions of short-term investments
Sales and redemptions of long-term investments
Purchases of other assets
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from issuance of term loan, net of issuance costs
Repayment of term loan
Proceeds from issuance of convertible debt, net of issuance costs
Payments of contingent consideration
Purchase of convertible note hedge
Proceeds from sale of warrants
Employee Stock Purchase Plan purchases
Proceeds from exercise of common stock options
Proceeds from Board of Directors stock purchases
Purchases of treasury stock
Effect of exchange rate changes on cash
Increase (decrease) in cash and cash equivalents
Net cash provided by financing activities
Proceeds from common stock offerings, net of transaction costs
Borrowings under Revolving Line of Credit
Payments under Revolving Line of Credit
Effect of exchange rate changes on cash
Decrease in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
Supplemental data:
Business acquisitions:
Fair value of assets acquired, net of cash acquired
Purchase consideration representing compensation
Fair value of liabilities assumed and contingent consideration
Fair value of warrants issued
Net cash paid for acquisitions
Interest paid

Comments